Literature DB >> 33542726

Editorial: TGF-β as a Key Regulator of NK and ILCs Development and Functions.

Cristina Bottino1,2, Thierry Walzer3, Angela Santoni4, Roberta Castriconi2.   

Abstract

Entities:  

Keywords:  ILC; NK cell metabolism; NK cells; NKG2D activating receptor; chemokine receptors; epigenetic mechanisms; transforming growth factor-β

Year:  2021        PMID： 33542726      PMCID： PMC7851045          DOI： 10.3389/fimmu.2020.631712

Source DB:  PubMed          Journal:  Front Immunol        ISSN： 1664-3224            Impact factor:   7.561


× No keyword cloud information.
  15 in total

1.  Canonical TGF-β Signaling Pathway Represses Human NK Cell Metabolism.

Authors:  Vanessa Zaiatz-Bittencourt; David K Finlay; Clair M Gardiner
Journal:  J Immunol       Date:  2018-05-02       Impact factor: 5.422

2.  Human tumor-derived exosomes down-modulate NKG2D expression.

Authors:  Aled Clayton; J Paul Mitchell; Jacquelyn Court; Seamus Linnane; Malcolm D Mason; Zsuzsanna Tabi
Journal:  J Immunol       Date:  2008-06-01       Impact factor: 5.422

3.  Targeted disruption of the mouse transforming growth factor-beta 1 gene results in multifocal inflammatory disease.

Authors:  M M Shull; I Ormsby; A B Kier; S Pawlowski; R J Diebold; M Yin; R Allen; C Sidman; G Proetzel; D Calvin
Journal:  Nature       Date:  1992-10-22       Impact factor: 49.962

4.  Enhanced preclinical antitumor activity of M7824, a bifunctional fusion protein simultaneously targeting PD-L1 and TGF-β.

Authors:  Yan Lan; Dong Zhang; Chunxiao Xu; Kenneth W Hance; Bo Marelli; Jin Qi; Huakui Yu; Guozhong Qin; Aroop Sircar; Vivian M Hernández; Molly H Jenkins; Rachel E Fontana; Amit Deshpande; George Locke; Helen Sabzevari; Laszlo Radvanyi; Kin-Ming Lo
Journal:  Sci Transl Med       Date:  2018-01-17       Impact factor: 17.956

Review 5.  New prospects on the NKG2D/NKG2DL system for oncology.

Authors:  Evelyn Ullrich; Joachim Koch; Adelheid Cerwenka; Alexander Steinle
Journal:  Oncoimmunology       Date:  2013-10-25       Impact factor: 8.110

6.  TGF-β1 Downregulates the Expression of CX3CR1 by Inducing miR-27a-5p in Primary Human NK Cells.

Authors:  Stefano Regis; Fabio Caliendo; Alessandra Dondero; Beatrice Casu; Filomena Romano; Fabrizio Loiacono; Alessandro Moretta; Cristina Bottino; Roberta Castriconi
Journal:  Front Immunol       Date:  2017-07-25       Impact factor: 7.561

7.  mTORC1 amplifies the ATF4-dependent de novo serine-glycine pathway to supply glycine during TGF-β1-induced collagen biosynthesis.

Authors:  Brintha Selvarajah; Ilan Azuelos; Manuela Platé; Delphine Guillotin; Ellen J Forty; Greg Contento; Hannah V Woodcock; Matthew Redding; Adam Taylor; Gino Brunori; Pascal F Durrenberger; Riccardo Ronzoni; Andy D Blanchard; Paul F Mercer; Dimitrios Anastasiou; Rachel C Chambers
Journal:  Sci Signal       Date:  2019-05-21       Impact factor: 8.192

8.  The metabolic checkpoint kinase mTOR is essential for IL-15 signaling during the development and activation of NK cells.

Authors:  Julien Cherfils-Vicini; Charlotte Viant; Antoine Marçais; Sophie Degouve; Sébastien Viel; Aurore Fenis; Jessica Rabilloud; Katia Mayol; Armelle Tavares; Jacques Bienvenu; Yann-Gaël Gangloff; Eric Gilson; Eric Vivier; Thierry Walzer
Journal:  Nat Immunol       Date:  2014-06-29       Impact factor: 25.606

9.  Novel Immunoregulatory Functions of IL-18, an Accomplice of TGF-β1.

Authors:  Beatrice Casu; Alessandra Dondero; Stefano Regis; Fabio Caliendo; Andrea Petretto; Martina Bartolucci; Francesca Bellora; Cristina Bottino; Roberta Castriconi
Journal:  Cancers (Basel)       Date:  2019-01-11       Impact factor: 6.639

Review 10.  NKG2D Ligand Shedding in Response to Stress: Role of ADAM10.

Authors:  Alessandra Zingoni; Elisabetta Vulpis; Luisa Loconte; Angela Santoni
Journal:  Front Immunol       Date:  2020-03-25       Impact factor: 7.561
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.